Inproceedings,

OMTX705, a powerful stroma-targeting ADC to treat invasive tumors with low response to immunotherapeutic anti-PD-1 treatments

, , , , , , , , , , and .
Abstract Book of the 43rd ESMO Congress (ESMO 2018), 29, Suppl. 8, page 414. Elsevier, Oxford Univ. Press, (2018)

Meta data

Tags

Users

  • @unibiblio

Comments and Reviews